Medical Marijuana Market Expected to Experience Major Growth by 2032, According to DelveInsight | Indivior, NFL Biosciences, Aelis Farma

DelveInsight's "Medical Marijuana Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Medical Marijuana, historical and forecasted epidemiology as well as the Medical Marijuana market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Medical Marijuana market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Medical Marijuana Market Forecast
https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Medical Marijuana Market Report:
• The Medical Marijuana market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In March 2025, Aelis Farma has announced the final analysis of its groundbreaking Phase 2B clinical trial evaluating AEF0117 for Cannbis Use Disorder (CUD). This trial aimed to assess the effectiveness of AEF0117 in reducing cannbis consumption and to identify optimal endpoints and dosing for future research. AEF0117, the first compound from a novel class known as CB1-SSi (signaling-specific inhibitors), demonstrated a favorable safety profile and was well tolerated. Importantly, it did not trigger psychiatric side effects-such as anxiety, depression, or suicidality-that are commonly associated with conventional CB1 antagonists, highlighting its potential as a safer therapeutic option for CUD.
• According to a research study in by Patel & Marwaha (2029), nearly 4% of the global population was using cannbis in 2015. Amongst teenagers, 8% in the US and 16% in Europe reported using cannbis
• The number of cannbis users in the general population was estimated at approximately 1.3 million people.
• Cannbis use increased between 2015 and 2017. In 2017, the lifetime prevalence of cannbis use was greater than that of inhalants, and cannbis had become the most abused drug in Japan (Shimane et al., 2020)
• According to the Centers for Disease Control and Prevention (CDC), the number of marijuana-related ED visits for adolescents aged 15-17 years was 61% higher in 2011 than in 2005. Visits among males increased 65%, while visits among females increased 53%
• Key Medical Marijuana Companies: Indivior, NFL Biosciences, Aelis Farma, and others
• Key Medical Marijuana Therapies: AEF0117, NFL-102, AEF0117, and others
• Approximately 4.8 million people 12 years or older (or 1.8%) had Medical Marijuana in the past year, according to 2019 data from the National Survey on Drug Use and Health. This rate has remained relatively stable since 2002
• The Medical Marijuana market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Medical Marijuana pipeline products will significantly revolutionize the Medical Marijuana market dynamics.

Medical Marijuana Overview
Cannbis (also called marijuana) is the third most commonly used psychoactive substance worldwide, after alcohol and tobacco (nicotine). Cannbis can be administered by various methods including smoking, vaping, dabbing, ingesting (edibles, beverages, and tinctures), and topical cream. Medical Marijuana develops in approximately 10% of regular cannbis users and up to 50% of chronic daily users and may be associated with cognitive impairment, poor school or work performance, and psychiatric comorbidity such as mood disorders and psychosis.

Get a Free sample for the Medical Marijuana Market Report:
https://www.delveinsight.com/report-store/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Medical Marijuana Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Medical Marijuana Epidemiology Segmentation:
The Medical Marijuana market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Medical Marijuana
• Prevalent Cases of Medical Marijuana by severity
• Gender-specific Prevalence of Medical Marijuana
• Diagnosed Cases of Episodic and Chronic Medical Marijuana

Download the report to understand which factors are driving Medical Marijuana epidemiology trends @ Medical Marijuana Epidemiology Forecast
https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Medical Marijuana Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Medical Marijuana market or expected to get launched during the study period. The analysis covers Medical Marijuana market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Medical Marijuana Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Medical Marijuana Therapies and Key Companies
• AEF0117: Indivior
• NFL-102: NFL Biosciences
• AEF0117: Aelis Farma

Discover more about therapies set to grab major Medical Marijuana market share @ Medical Marijuana Treatment Market
https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Medical Marijuana Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Medical Marijuana Companies: Indivior, NFL Biosciences, Aelis Farma, and others
• Key Medical Marijuana Therapies: AEF0117, NFL-102, AEF0117, and others
• Medical Marijuana Therapeutic Assessment: Medical Marijuana current marketed and Medical Marijuana emerging therapies
• Medical Marijuana Market Dynamics: Medical Marijuana market drivers and Medical Marijuana market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Medical Marijuana Unmet Needs, KOL's views, Analyst's views, Medical Marijuana Market Access and Reimbursement

To know more about Medical Marijuana companies working in the treatment market, visit @ Medical Marijuana Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Medical Marijuana Market Report Introduction
2. Executive Summary for Medical Marijuana
3. SWOT analysis of Medical Marijuana
4. Medical Marijuana Patient Share (%) Overview at a Glance
5. Medical Marijuana Market Overview at a Glance
6. Medical Marijuana Disease Background and Overview
7. Medical Marijuana Epidemiology and Patient Population
8. Country-Specific Patient Population of Medical Marijuana
9. Medical Marijuana Current Treatment and Medical Practices
10. Medical Marijuana Unmet Needs
11. Medical Marijuana Emerging Therapies
12. Medical Marijuana Market Outlook
13. Country-Wise Medical Marijuana Market Analysis (2019-2032)
14. Medical Marijuana Market Access and Reimbursement of Therapies
15. Medical Marijuana Market Drivers
16. Medical Marijuana Market Barriers
17. Medical Marijuana Appendix
18. Medical Marijuana Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Latest Reports by DelveInsight
• Prediabetes Market: https://www.delveinsight.com/report-store/prediabetes-market
• Scoliosis Market: https://www.delveinsight.com/report-store/scoliosis-market
• Psoriasis Market: https://www.delveinsight.com/report-store/psoriasis-market
• Tendinitis Market: https://www.delveinsight.com/report-store/tendonitis-market
• Vascular Closure Devices Market: https://www.delveinsight.com/report-store/vascular-closure-devices-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Hydrocephalus Market: https://www.delveinsight.com/report-store/hydrocephalus-market
• Hemophilia A Market: https://www.delveinsight.com/report-store/hemophilia-a2030-market
• Herpes Simplex Virus Market: https://www.delveinsight.com/report-store/genital-herpes-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.